Inovio Pharmaceuticals
INO
INO
174 hedge funds and large institutions have $99.8M invested in Inovio Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 49 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
-9
Holders Change %
-4.92%
% of All Funds
2.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
48
Reduced
49
Closed
30
Calls
$679K
Puts
$351K
Net Calls
+$328K
Net Calls Change
-$24K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$15M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$966K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
$2.89M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$788K |
| 5 |
Citigroup
New York
|
$1.53M |
Top Sellers
| 1 |
Millennium Management
New York
|
$0 |
| 2 |
State Street
Boston,
Massachusetts
|
$22.9M |
| 3 |
D.E. Shaw & Co
New York
|
$5.43M |
| 4 |
Two Sigma Advisers
New York
|
$16.9K |
| 5 |
Two Sigma Investments
New York
|
$0 |
